Analysed TONIX PHARMACEUTICALS HOLDIN (TNXP:NASDAQ) News Sources
Tonix Pharmaceuticals Announces Publication of Steady-State Pharmacokinetics of TONMYA® After 20 Days of Daily Dosing in the Peer-Reviewed Journal, Clinical Pharmacology in Drug Development
15-04-2026
yahoo.com
Tonix Pharmaceuticals Announces Presentation of Phase 1 Data and Outlines Planned Adaptive Phase 2 Field Study of TNX-4800 for the Prevention of Lyme Disease, at the World Vaccine Congress Washington 2026
31-03-2026
yahoo.com
Tonix Pharmaceuticals Announces First Participant Dosed in Phase 1 Investigator-Initiated Pharmacodynamic Study of TNX-1900 (Intranasal Potentiated Oxytocin) to Assess Potential for Treating Migraine and Craniofacial Pain
26-03-2026
yahoo.com
Tonix Pharmaceuticals Announces Presentations at World Vaccine Congress Washington 2026
23-03-2026
yahoo.com
TNXP: ~2500 Patients Have Initiated Treatment with Tonmya Following November 2025 Commercial Launch
23-03-2026
yahoo.com
Tonix Pharmaceuticals Announces Oral Presentation and Two Poster Presentations on Preclinical Immuno-oncology Portfolio at the American Association for Cancer Research (AACR) Annual Meeting 2026
17-03-2026
yahoo.com
OTC Markets Hosts Virtual Investor Presentation with Dr. Seth Lederman, Co-Founder, CEO, and Chairman of Tonix Pharmaceuticals, and David Bautz, PhD, Senior Analyst at Zacks SCR
16-03-2026
yahoo.com
Life Sciences Virtual Investor Forum Presentations Now Available for Online Viewing
13-03-2026
yahoo.com
What is the current price of TONIX PHARMACEUTICALS HOLDIN (TNXP:NASDAQ)?
The current price of TONIX PHARMACEUTICALS HOLDIN (TNXP:NASDAQ) is $14.13.
TONIX PHARMACEUTICALS HOLDIN (TNXP:NASDAQ) absolute price change since previous trading day?
The absolute price change of TONIX PHARMACEUTICALS HOLDIN (TNXP:NASDAQ) since the previous trading day is $-0.21.
TONIX PHARMACEUTICALS HOLDIN (TNXP:NASDAQ) percentage price change since previous trading day?
The percentage price change of TONIX PHARMACEUTICALS HOLDIN (TNXP:NASDAQ) since the previous trading day is -1.4644%.
What is the most recent average sentiment score for TONIX PHARMACEUTICALS HOLDIN (TNXP:NASDAQ)?
The most recent average sentiment score for TONIX PHARMACEUTICALS HOLDIN (TNXP:NASDAQ) is 86 out of 100.
What is the most recent average sentiment for TONIX PHARMACEUTICALS HOLDIN (TNXP:NASDAQ)?
The most recent sentiment for TONIX PHARMACEUTICALS HOLDIN (TNXP:NASDAQ) is .
SEC-8K** Filing Available For TONIX PHARMACEUTICALS HOLDIN (TNXP:NASDAQ)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.